A61P 31/02
Local antiseptics
A61P31/02 (Local antiseptics) appears on 954 US grants and 1,523 published applications in this corpus.
Search patents in A61P- Granted patents
- 954
- Published applications
- 1,523
- Assignees
- 798
- Inventors
- 2,772
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 13 | 0 |
| 1999 | 10 | 0 |
| 2000 | 18 | 0 |
| 2001 | 21 | 5 |
| 2002 | 25 | 32 |
| 2003 | 24 | 32 |
| 2004 | 17 | 46 |
| 2005 | 13 | 57 |
| 2006 | 19 | 52 |
| 2007 | 12 | 67 |
| 2008 | 17 | 61 |
| 2009 | 18 | 67 |
| 2010 | 44 | 120 |
| 2011 | 27 | 100 |
| 2012 | 40 | 76 |
| 2013 | 72 | 68 |
| 2014 | 69 | 89 |
| 2015 | 55 | 88 |
| 2016 | 61 | 74 |
| 2017 | 58 | 55 |
| 2018 | 46 | 71 |
| 2019 | 51 | 47 |
| 2020 | 45 | 55 |
| 2021 | 37 | 51 |
| 2022 | 25 | 58 |
| 2023 | 26 | 57 |
| 2024 | 28 | 36 |
| 2025 | 29 | 37 |
| 2026 | 18 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for disrupting biofilm formation and for treating biofilm-related disorders18 Aug 2026US 12,708,612 B2AHV International B.V.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)12 May 2026US 12,624,028 B2Vertex Pharmaceuticals Incorporated
- Compositions and methods for the treatment of skin diseases and conditions including eczema21 Apr 2026US 12,605,416 B2Phi Therapeutics, Inc.
- Injectable bifunctional hydrogel with antibacterial activity as well as the preparative method and the use thereof31 Mar 2026US 12,589,108 B2Sichuan University
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Therapeutic effect of molecules derived from probiotic milk-based fermentation microbial consortium ("kefir") on wounds healing3 Sep 2026US 2026/0256739 A1B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- Polysaccharide-Rich Bombax Costatum Flower Extract3 Sep 2026US 2026/0256864 A1Laboratoires Expanscience
- Method for transient acidification of wounds27 Aug 2026US 2026/0248842 A1SePRO Corporation
- Antimicrobial Compositions with 1,2-Alkanediols30 Jul 2026US 2026/0216104 A1Solventum Intellectual Properties Company
Most cited
By later US patents
- Stable hydroalcoholic compositions215US 5,951,993 AMinnesota Mining and Manufacturing Company · 1999
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Antibacterial antiplaque oral composition189US 4,894,220 AColgate-Palmolive Company · 1990
- Thioether substituted imidazoquinolines177US 6,664,264 B23M Innovative Properties Company · 2003
- Thioether substituted imidazoquinolines167US 6,667,312 B23M Innovative Properties Company · 2003